Individualized prophylaxis for optimizing hemophilia care: can we apply this to both developed and developing nations?

[1]  T. Dutta,et al.  A randomized study of very low‐dose factor VIII prophylaxis in severe haemophilia – A success story from a resource limited country , 2016, Haemophilia : the official journal of the World Federation of Hemophilia.

[2]  Adrienne Lee,et al.  Low-dose tertiary prophylactic therapy reduces total number of bleeds and improves the ability to perform activities of daily living in adults with severe haemophilia A: a single-centre experience from Beijing , 2016, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[3]  C. Santoro,et al.  Benefits of prophylaxis versus on-demand treatment in adolescents and adults with severe haemophilia A: the POTTER study , 2015, Thrombosis and Haemostasis.

[4]  J. Oldenburg.  Optimal treatment strategies for hemophilia: achievements and limitations of current prophylactic regimens. , 2015, Blood.

[5]  A. Gringeri,et al.  The burden of bleeding in haemophilia: is one bleed too many? , 2014, Haemophilia : the official journal of the World Federation of Hemophilia.

[6]  B. Verbruggen,et al.  Laboratory testing for factor inhibitors , 2014, Haemophilia : the official journal of the World Federation of Hemophilia.

[7]  R. Ljung,et al.  Intermediate-dose versus high-dose prophylaxis for severe hemophilia: comparing outcome and costs since the 1970s. , 2013, Blood.

[8]  C. Kempton,et al.  Randomized, controlled, parallel‐group trial of routine prophylaxis vs. on‐demand treatment with sucrose‐formulated recombinant factor VIII in adults with severe hemophilia A (SPINART) , 2013, Journal of thrombosis and haemostasis : JTH.

[9]  X. Zhang,et al.  Short‐term low‐dose secondary prophylaxis for severe/moderate haemophilia A children is beneficial to reduce bleed and improve daily activity, but there are obstacle in its execution: a multi‐centre pilot study in China , 2013, Haemophilia : the official journal of the World Federation of Hemophilia.

[10]  J. Mahlangu,et al.  Guidelines for the management of hemophilia , 2013, Haemophilia : the official journal of the World Federation of Hemophilia.

[11]  L. Mantovani,et al.  A randomized clinical trial of prophylaxis in children with hemophilia A (the ESPRIT Study) , 2011, Journal of thrombosis and haemostasis : JTH.

[12]  R. Wu,et al.  Low dose secondary prophylaxis reduces joint bleeding in severe and moderate haemophilic children: a pilot study in China , 2011, Haemophilia : the official journal of the World Federation of Hemophilia.

[13]  F. Rosendaal,et al.  Analysis of low frequency bleeding data: the association of joint bleeds according to baseline FVIII activity levels , 2011, Haemophilia : the official journal of the World Federation of Hemophilia.

[14]  H. Hazewinkel,et al.  Very rapid clearance after a joint bleed in the canine knee cannot prevent adverse effects on cartilage and synovial tissue. , 2009, Osteoarthritis and cartilage.

[15]  V. Blanchette,et al.  Cost‐utility analysis of Canadian tailored prophylaxis, primary prophylaxis and on‐demand therapy in young children with severe haemophilia A , 2008, Haemophilia : the official journal of the World Federation of Hemophilia.

[16]  Alan R. Cohen,et al.  Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia. , 2007, The New England journal of medicine.

[17]  V. Blanchette,et al.  A survey of factor prophylaxis in boys with haemophilia followed in North American haemophilia treatment centres , 2003, Haemophilia : the official journal of the World Federation of Hemophilia.

[18]  M. Siimes,et al.  Treatment of children with haemophilia in Europe: a survey of 20 centres in 16 countries , 2000, Haemophilia : the official journal of the World Federation of Hemophilia.

[19]  Sultan,et al.  Epidemiological survey of the orthopaedic status of severe haemophilia A and B patients in France , 2000, Haemophilia : the official journal of the World Federation of Hemophilia.

[20]  A. Chuansumrit,et al.  Prophylactic treatment for hemophilia A patients: a pilot study. , 1995, The Southeast Asian journal of tropical medicine and public health.

[21]  D. Thomas.  Pharmacokinetic studies on a new purified factor IX concentrate , 1995, Haemophilia : the official journal of the World Federation of Hemophilia.

[22]  H. Pettersson,et al.  A longitudinal study of orthopaedic outcomes for severe factor‐VIII‐deficient haemophiliacs , 1994, Journal of internal medicine.

[23]  H. Pettersson,et al.  Twenty‐five years' experience of prophylactic treatment in severe haemophilia A and B , 1992, Journal of internal medicine.